Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Program of Cancer Registries Cancer Surveillance System. This information collection provides useful data on cancer incidence and trends.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 222 (Monday, November 22, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 222 (Monday, November 22, 2021)]
[Notices]
[Pages 66308-66309]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-25448]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-0469; Docket No. CDC-2021-0123]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled National Program of Cancer
Registries Cancer Surveillance System. This information collection
provides useful data on cancer incidence and trends.
DATES: CDC must receive written comments on or before January 21, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0123 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://Regulations.gov">Regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#4e21232c0e2d2a2d60292138"><span class="__cf_email__" data-cfemail="f29d9f90b2919691dc959d84">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Program of Cancer Registries Cancer Surveillance System
(OMB Control No. 0920-0469, Exp. 12/31/2022)--Revision--National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
In 2018, the most recent year for which complete incidence
information is available, almost 600,000 people died of cancer and more
than 1.7 million were diagnosed with cancer. It is estimated that 16.3
million Americans are currently alive with a history of cancer. In the
United States, state/territory-based central cancer registries (CCR)
are the only method for systematically collecting and reporting
population-based information about cancer incidence and outcomes such
as survival. These data are used to measure the changing incidence and
burden of
[[Page 66309]]
each cancer; identify populations at increased or increasing risk;
target preventive measures; and measure the success or failure of
cancer control efforts in the United States.
In 1992, Congress passed the Cancer Registries Amendment Act which
established the National Program of Cancer Registries (NPCR). The NPCR
provides support for state/territory-based cancer registries that
collect, manage, and analyze data about cancer cases. The state/
territory-based cancer registries report information to CDC through the
National Program of Cancer Registries Cancer Surveillance System (NPCR
CSS), (OMB No. 0920-0469, Exp. 12/31/2022). CDC plans to request OMB
approval to continue collecting this information for three years. Data
definitions will be updated to reflect changes in national standards
for cancer diagnosis and coding. No changes to the total estimated
annualized burden hours or number of respondents are anticipated.
The NPCR CSS allows CDC to collect, aggregate, evaluate, and
disseminate cancer incidence data at the national level. The NPCR CSS
is the primary source of information for the United States Cancer
Statistics (USCS), which CDC has published annually since 2002. The
latest USCS report, published in 2021, provided cancer statistics for
99% of the U.S. population from all cancer registries in the United
States. Prior to the publication of USCS, cancer incidence data at the
national level were available for only 14% of the population of the
United States.
The NPCR CSS also allows CDC to monitor cancer trends over time,
describe geographic variation in cancer incidence throughout the
country, and provide incidence data on racial/ethnic populations and
rare cancers. These activities and analyses further support CDC's
planning and evaluation efforts for state and national cancer control
and prevention. In addition, datasets can be made available for
secondary analysis.
Respondents are NPCR-supported central cancer registries (CCR) in
46 U.S. states, three territories, and the District of Columbia. Fifty
CCRs submit data elements specified for the Standard NPCR CSS Report.
Each CCR is asked to transmit two data files to CDC per year. The first
NPCR CSS Standard file, submitted in January, is a preliminary report
consisting of one year of data for the most recent year of data
available. CDC evaluates the preliminary data for completeness and
quality and provides a report back to the CCR. The second NPCR CSS
Standard file, submitted by November, contains cumulative cancer
incidence data from the first diagnosis year for which the cancer
registry collected data with the assistance of NPCR funds (e.g., 1995)
through 12 months past the close of the most recent diagnosis year
(e.g., 2018). The cumulative file is used for analysis and reporting.
The burden for each file transmission is estimated at two hours per
response. Because cancer incidence data are already collected and
aggregated at the state level, the additional burden of reporting the
information to CDC is small.
All information is transmitted to CDC electronically. Participation
is required as a condition of the cooperative agreement with CDC. CDC
requests approval for an estimated 200 annual burden hours. There are
no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Central Cancer Registries in Standard NPCR 50 2 2 200
States, Territories, and the CSS Report.
District of Columbia.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 200
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-25448 Filed 11-19-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.